Mary-Ellen Taplin

7PUBLICATIONS

153CO-AUTHORS

Predictive and prognostic markersMolecular targetsRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 01, 2026

Perioperative Apalutamide in High-Risk Localized Prostate Cancer.

|May 11, 2026

Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Nov 20, 2025

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Aug 12, 2025

Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben

|Mar 29, 2024

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.

Atish D Choudhury, Lucia Kwak, Alexander Cheung

|Sep 12, 2023

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.

Martin S Taylor, Connie Wu, Peter C Fridy

Pageof 2

Frequent Collaborators

David J Einstein

Glenn J Bubley

Steven P Balk

Atish D Choudhury

Toni K Choueiri

Amanda Pace

Eliezer M Van Allen

Mark Pomerantz

David D Yang

Christopher Sweeney

Frequent Collaborators

David J Einstein

Glenn J Bubley

Steven P Balk

Atish D Choudhury